Quizlet
or
There are no sets in this subject.
No groups found.
| metoclopramide definitions | |||
|---|---|---|---|
| # | Definition | Sets | |
| 1 | reglan | 28 sets | |
| 2 | maxeran | 15 sets | |
| 3 | antiemetic | 3 sets | |
| 4 | maxolon, reglan | 2 sets | |
| 5 | gi drugs, prokinetic agent (d2 antagonist, 5-ht3 antagonists, 5-ht-4 agonist) | 2 sets | |
| 6 | gi stimulant, antiemetic; 5ht4+, da- -> stimulates myenteric ach release -> incr gastric motility | 1 set | |
| 7 | cholinergic agonist, adrenergic antagonist | 1 set | |
| 8 | dopamine receptor antagonist | 1 set | |
| 9 | gi: antiemetic, d2 receptor antagonists; also a prokinetic ; by binding to 5 ht3 receptor; ae: hyperprolactinemia, infertility, etrapyramidal symptoms | 1 set | |
| 10 | dopamine receptor | 1 set | |
| 11 | a/emetic | 1 set | |
| 12 | reglan-used in treatment of nasea and vomiting | 1 set | |
| 13 | muscarinic agonist: combined cholinergic agonist and dopamine antagonist, replace bethanecol in gastroparesis (inadequate stomach empty) or gerd | 1 set | |
| 14 | at higher doses this anti-emetic causes neurological effects. | 1 set | |
| 15 | raglan | 1 set | |
| 16 | gastric motility agent/antiemetic | 1 set | |
| 17 | reglan ( anti dopa / emet ) | 1 set | |
| 18 | in addition to being a dopamine antagonist at the crtz, this drug also increases lower esophageal sphincter tone and increases gi motility. | 1 set | |
| 19 | dopamine antagonist at the crtz. at high doses may be 5-ht3 receptor antagonist. | 1 set | |
| 20 | muscarinic antagonist: gi motility, prevent chemo vomit, side effect: extrapyramidal, restlessness, drowsiness, fatigue, nausea, dry mouth, diarrhea/constipation (don't use with pheochromocytoma, seizure, antipsych) linked to tardive dyskinesia | 1 set | |
| 21 | m antagonist (gi motility) | 1 set | |
| 22 | example of d2 antagonist | 1 set | |
| 23 | antiemetic adjunctive medicine for treating associated gi symptoms that often accompany migraine | 1 set | |
| 24 | reglan antiemetic; gi stimulant diabetic gastroparesis, gastroesophageal reflux | 1 set | |
| 25 | dopamine antagonist, increase gi pressure and motility, prevents reflux, does not affect gastric acid secretion, use as an anti-emetic, to hasten passage of barium contrast media, to relieve gastroparesis in diabetics, with morphine to prevent opiate-induced constipation, with golytely or magnesium sulfate to evacuate bowel for colonoscopy, side effects include drowsiness, lassitude, excessive bowel movements | 1 set | |
| 26 | reglan depression, hypertensive crisis, tardivedyskinesia,extrapyramidal symptoms and parkinsonian like symptoms | 1 set | |
| 27 | potent dopamine receptor antagonist ,antiemetic and prokinetic properties. treat nausea and vomiting, and to facilitate gastric emptying in patients with gastroparesis. | 1 set | |
| 28 | blocks d2 receptors in the area postrema | 1 set | |
| 29 | prokinetic agent used to block emesis | 1 set | |
| 30 | gi drugs, antiemetics, d2 receptor antagonists | 1 set | |
| 31 | facilitates acetylcholine while blocking dopamine in the enteric nervous system | 1 set | |
| 32 | se are sedation, diarrhea, extrapyramidal symptoms | 1 set | |
| 33 | d2 receptor antagonist, increases resting tone, contractility, les tone, motility, does not influence colon transit time; used to treat diabetic and post surgery gastroparesis; can cause parkinsonian effects, restlessness, drowsiness, fatigue, depression, nausea, diarrhea (contraindicated in patients with small bowel obstruction) | 1 set | |
| 34 | a | 1 set | |
| 35 | n & v | 1 set | |
| 36 | reglan, anti-emetic, gerd | 1 set | |
| 37 | gi drugs; prokinetic agent (d2 antagonist, 5-ht3 antagonist, 5-ht4 agonist) | 1 set | |
| 38 | antimedic | 1 set | |
| 39 | reglan (antiemetic) | 1 set | |
| 40 | 5ht4 agonist gerd and produces extapyramidal effects; tachycardia | 1 set | |